Cancer Biology and Cell Science

Cancer Genomics & Metabolomics

A branch of genomics called oncogenomics studies the characteristics of genes that are connected to or associated with cancer. It mainly focuses on transcript, epigenomic, and genomic changes in cancer. Oncogenomics' major goal is to identify new oncogenes or tumour suppressor genes that could open up new avenues for study into cancer diagnosis, cancer prognosis, and potential new targets for cancer treatments. Targeted cancer medicines like Gleevec, Herceptin, and Avastin have made it possible for oncogenomics to identify novel cancer therapeutic targets. The term "metabolomics" refers to the entire range of small-molecule metabolites, which allows for the systematic analysis of distinct chemical fingerprints that leave cellular activities in the dust. It is a relatively young topic of "omics" research. The collection is represented by the metabolome.